Compliance Rate
Compliance Rate
0.0%
Compliant submissions
0
Incompliant submissions
1
Total trials
1
My Organizations' Clinical Trials
Showing 300 of 361 entries
View as:
A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease
Phase: N/A
Priority: Normal
Start: 07/31/03
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/07
End: 11/30/10
Due: 11/30/11
Phase: N/A
Priority: Normal
Start: 12/31/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/11
End: 07/31/12
Due: 07/31/13
Phase: N/A
Priority: Normal
Start: 11/30/03
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/27/20
End: 05/18/21
Due: 05/18/22
Phase: N/A
Priority: Normal
Start: 09/30/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/29/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/06
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/05
End: 06/30/08
Due: 06/30/09
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 04/30/11
Due: 04/30/12
Phase: N/A
Priority: Normal
Start: 08/31/09
End: 05/31/10
Due: 05/31/11
Phase: N/A
Priority: Normal
Start: 04/30/05
End: 06/30/06
Due: 06/30/07
Phase: N/A
Priority: Normal
Start: 09/30/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/24
End: 02/28/25
Due: 02/28/26
Phase: N/A
Priority: Normal
Start: 03/03/20
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 09/30/02
End: 01/31/05
Due: 01/31/06
Phase: N/A
Priority: Normal
Start: 08/31/14
End: 03/31/15
Due: 03/31/16
Phase: N/A
Priority: Normal
Start: 01/24/18
End: 07/01/19
Due: 07/01/20
Phase: N/A
Priority: Normal
Start: 05/31/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -